1 / 20

François Schiele , MD, PhD, Nicolas Meneveau , MD, PhD,

Effects of Clinical Characteristics and Treatments on Gender Difference in Outcomes after Acute Myocardial Infarction. A propensity score-matched analysis. François Schiele , MD, PhD, Nicolas Meneveau , MD, PhD, Marie France Seronde , MD, Vincent Descotes-Genon , MD,

nico
Download Presentation

François Schiele , MD, PhD, Nicolas Meneveau , MD, PhD,

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Effects of Clinical Characteristics and Treatments on Gender Difference in Outcomes after Acute Myocardial Infarction. A propensity score-matched analysis François Schiele, MD, PhD, Nicolas Meneveau, MD, PhD, Marie France Seronde, MD, Vincent Descotes-Genon, MD, Joanna Dutheil, MD, RomainChopard, MD, Fiona Ecarnot, and Jean-Pierre Bassand, MD. On behalf on the “Reseau de Cardiologie de FrancheComté” Department of Cardiology, University Hospital Jean Minjoz, Besançon, France. Conflict of Interest to Declare : Research Contracts and Consulting Servier, Sanofi, GSK, Astra-Zeneca, Takeda, Lilly

  2. Women fare worse than men after acute MI • Women admitted for acute MI have 40-100% higher mortality at 30 days, as compared with men. This over-mortality is reduced after adjustment for age and co-morbidities. Malacrida, ISIS-3, N Engl J Med 1998;338:8-14

  3. Women fare worse than men after acute MI • Women admitted for acute MI have 40-100% higher mortality at 30 days, as compared with men. This over-mortality is reduced after adjustment for age and co-morbidities. • Sex-age interaction : discrepancy between studies • Greater difference with older age • Decrease in difference with age Malacrida, N Engl J Med 1998;338:8-14 Vaccarino, N Engl J Med 1999;341:217-25

  4. Women fare worse than men after acute MI • Women admitted for acute MI have 40-100% higher mortality at 30 days, as compared with men. This over-mortality is reduced after adjustment for age and co-morbidities. • Sex-age interaction : discrepancy between studies • Sex-type of MI interaction : STEMI ≠ NSTEMI Berger, JAMA 2009;302:874-82

  5. Women fare worse than men after acute MI • Women admitted for acute MI have 40-100% higher mortality at 30 days, as compared with men. This over-mortality is reduced after adjustment for age and co-morbidities. • Sex-age interaction : discrepancy between studies • Sex-Type of MI interaction : STEMI ≠ NSTEMI • Women receive fewer treatments and no difference in mortality is observed after adjustment for co-morbidities and treatments Gan, N Engl J Med 2000;343:8-15

  6. Women fare worse than men after acute MI • Women admitted for acute MI have 40-100% higher mortality at 30 days, as compared with men. This over-mortality is reduced after adjustment for age and co-morbidities. • Sex-age interaction : discrepancy between studies • Sex-Type of MI interaction : STEMI ≠ NSTEMI • Women receive fewer treatments and no difference in mortality is observed after adjustment for co-morbidities and treatments Aim of the Study To assess the effects of Clinical Characteristics and Treatments on Gender Difference , using a Propensity Score-Matched Analysis.

  7. Methods • All consecutive patients admittedbetweenJanuary 2006 and December2007 • CARDS dataset, dedicated team of data managers. • Endpoint: 30 day all-cause mortality • Use of matched pairs comparison: • TwoPropensityscores for being male by logisticregression, • PS#1 withbaselinecharacteristics (16 variables) • PS#2 withbaselinecharacteristics and treatments • 1:1 matchingon best 8 digits of the propensity score (match allowed for PS<0.015) • 30 daymortality (Kaplan Meier curves and Oddsratios fromconditionallogisticregression) in unadjusted and matchedcohorts • Interactions : age, type of MI (STEMI vs NSTEMI).

  8. Baseline characteristics (1)

  9. Baseline characteristics (2)

  10. In-hospital Treatments

  11. Selection of the matched populations 3510 patients with Acute Myocardial Infarction 1578 (45%) STEMI, 1932 (55%) NSTEMI 1119 (32%) Women, 2391 (68%) Men Propensity score 1 (being male) with baseline characteristics Propensity score 2 (being male) with baseline characteristics and treatments Matching on propensity score 1 = 649 pairs Matching on propensity score 2 = 584 pairs Comparison of mortality Comparison of treatments Comparison of mortality

  12. Effect of matching on sex differences 0.05 P values for the differencebetween men and women Unmatcheddataset

  13. Effect of matching on sex differences 0.05 P values for the differencebetween men and women Unmatcheddataset Matched #1 dataset

  14. Effect of matching on sex differences 0.05 P values for the differencebetween men and women Unmatcheddataset Matched #1 dataset Matched #2 dataset

  15. Women Men Log-Rank test: p=0.95 Days 0 5 10 20 30 At risk 584 574 565 544 529 584 573 562 550 530 KM Cumulative mortality Unmatched n=3510 p=0.001 Matched #1 n=649 pairs p=0.23 Matched #2 n=584 pairs p=0.95 Unmatched n=3510 p=0.001 Unmatched n=3510 p=0.001 Matched #1 n=649 pairs p=0.23

  16. Aspirin unmatched OR= 1.35 [1.06; 1.80] Matched #1 OR= 1.10 [0.46; 2.62] Clopidogrel unmatched OR= 1.65 [1.38; 2.01] Matched #1 OR= 1.04 [0.58; 1.84] Aspirin and Clopidogel unmatched OR= 1.67 [1.40; 2.01] Matched #1 OR= 1.10 [0.46; 1.63] ACEI or ARB unmatched OR= 1.42 [1.24; 1.65] Matched #1 OR= 1.29 [0.97; 1.70] Beta blocker unmatched OR= 1.31 [1.15; 1.49] Matched #1 OR= 1.02 [0.64; 1.29] GPIIbIIIa (NSTEMI) unmatched OR= 1.66 [1.43; 1.96] Matched #1 OR= 1.40 [0.94; 1.56] CoronaryAngiography unmatched OR= 2.82 [2.40; 3.41] Matched #1 OR= 1.57 [1.10; 2.18] Reperfusion /PPCI unmatched OR= 1.56 [1.29; 1.89] Matched #1 OR= 1.24 [1.12; 1.71] Reperfusion /FL unmatched OR= 1.82 [1.24; 2.12] Matched #1 OR= 1.72 [1.08; 2.73] In-Hospitalmortality unmatched OR= 0.50 [0.37; 0.62] Matched #1 OR= 0.52 [0.32; 0.83] Matched #2 OR= 0.75 [0.45; 1.23] 30 daymortality unmatched OR= 0.53 [0.42; 0.57] Matched #1 OR= 0.70 [0.46; 1.01] Matched #2 OR= 0.89 [0.57; 1.36] 0.5 0.8 1 1.5 2 4 Odds ratios for men versus women

  17. Sub-groups (1) Interaction betweenGender and type of MI P=0.009 P=0.009 P=0.009 P=0.36 P=0.36 P=0.13 Mortality more than twice as high in womenthan in men in STEMI, but no difference in NSTEMI patients; significant interaction No highermortality and no interaction afteradjustment for characteristics No highermortality and no interaction afteradjustment for characteristics and treatments

  18. Sub-groups (2) Interaction betweenGender and Age: differenceaccording to meanage Unadjustedcohort Sex-age interaction P=0.002 Matched #1 Sex-age interaction P=0.005 Matched #2 No sex-age interaction P=0.16

  19. Discussion • Matchingon propensityscore withanalysisby pairs • Differences in characteristics, treatments and mortality • Sex-age interaction : significant interaction withgreatergenderdifference in older patients, disappearsaftermatching. • Sex-type of MI interaction disappearsaftermatching • Sexdifferences in aspirin, clopidogrel, betablockers, ACEI and statins are explained by characteristics. • Sexdifferences in coronaryangiography and reperfusion in STEMI are not explained by characteristics • No difference in mortalityaftermatching on characteristics and treatments. Vaccarino, New Engl J Med 1999 Austin, Use of PS.., Stat Med 2005 Blomkalns, CRUSADE, JACC 2005;45:832-7 RosengrenEur Heart J 2001; 22: 314–322, Milcent Circulation. 2007;115:833-839 Berger, JAMA 2009;302:874-82

  20. Conclusions • As comparedwith men, womenadmitted for acute MI receivefewer effective treatments and have a twofoldhigher 30 daymortality. • Comparison of cohortsmatched on baselinecharacteristics shows thatco-morbiditiesexplainthe lower use of treatments. Nevertheless, women are lessoftensubmitted to coronaryangiography and reperfusion (STEMI) and have a higher in-hospitalmortality. • Comparison of cohortsmatched on baselinecharacteristics and treatments shows similar in-hospital and 30 daymortalitybetweengenders, suggestingthat a higher use of invasive procedures and reperfusionstrategycouldreduce the difference in mortality.

More Related